DEL PRATO, STEFANO
 Distribuzione geografica
Continente #
NA - Nord America 50.793
EU - Europa 20.485
AS - Asia 9.292
AF - Africa 326
SA - Sud America 211
OC - Oceania 35
Continente sconosciuto - Info sul continente non disponibili 24
Totale 81.166
Nazione #
US - Stati Uniti d'America 44.834
CA - Canada 5.925
IT - Italia 5.845
CN - Cina 5.439
PL - Polonia 3.835
SE - Svezia 2.694
BG - Bulgaria 2.017
SG - Singapore 1.595
UA - Ucraina 1.379
DE - Germania 1.375
TR - Turchia 922
GB - Regno Unito 855
FI - Finlandia 737
VN - Vietnam 700
CH - Svizzera 634
RU - Federazione Russa 451
HK - Hong Kong 297
FR - Francia 195
BR - Brasile 177
AT - Austria 168
CI - Costa d'Avorio 140
IN - India 117
BE - Belgio 88
SN - Senegal 80
NL - Olanda 41
NG - Nigeria 40
IR - Iran 39
IE - Irlanda 37
IL - Israele 33
KR - Corea 28
AU - Australia 27
BJ - Benin 26
MX - Messico 26
EU - Europa 23
ES - Italia 22
JP - Giappone 20
CZ - Repubblica Ceca 17
TW - Taiwan 16
EG - Egitto 15
GR - Grecia 15
LT - Lituania 14
IQ - Iraq 13
RO - Romania 13
PT - Portogallo 12
BD - Bangladesh 10
ID - Indonesia 10
PK - Pakistan 9
DK - Danimarca 8
EC - Ecuador 8
NZ - Nuova Zelanda 8
AR - Argentina 6
CL - Cile 6
MA - Marocco 6
MY - Malesia 6
NO - Norvegia 6
HR - Croazia 5
CO - Colombia 4
DZ - Algeria 4
EE - Estonia 4
JO - Giordania 4
KZ - Kazakistan 4
QA - Qatar 4
RS - Serbia 4
SC - Seychelles 4
TH - Thailandia 4
TN - Tunisia 4
VE - Venezuela 4
AZ - Azerbaigian 3
HU - Ungheria 3
NP - Nepal 3
UY - Uruguay 3
ZA - Sudafrica 3
AE - Emirati Arabi Uniti 2
BY - Bielorussia 2
CU - Cuba 2
GT - Guatemala 2
IS - Islanda 2
KE - Kenya 2
OM - Oman 2
PA - Panama 2
PE - Perù 2
SA - Arabia Saudita 2
SI - Slovenia 2
A1 - Anonimo 1
AL - Albania 1
AM - Armenia 1
BH - Bahrain 1
BN - Brunei Darussalam 1
DO - Repubblica Dominicana 1
GA - Gabon 1
JM - Giamaica 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
LK - Sri Lanka 1
MD - Moldavia 1
MM - Myanmar 1
MT - Malta 1
NE - Niger 1
Totale 81.162
Città #
Woodbridge 6.656
Ann Arbor 5.211
Montreal 4.601
Fairfield 4.434
Houston 4.382
Chandler 2.852
Ashburn 2.340
Milan 2.317
Sofia 2.012
Jacksonville 1.995
Seattle 1.810
Wilmington 1.597
Cambridge 1.501
Santa Clara 1.489
Shanghai 1.448
Ottawa 1.262
Beijing 1.187
New York 1.139
Singapore 937
Princeton 917
Boardman 863
Lawrence 782
Nanjing 712
Medford 673
Bern 628
Izmir 578
Serra 519
Des Moines 477
Jüchen 350
Dearborn 345
Istanbul 314
Nanchang 292
San Diego 287
Hong Kong 282
Dong Ket 254
Boulder 252
Rome 210
Redwood City 171
Kunming 165
Shenyang 149
Florence 146
Vienna 144
Abidjan 140
Falls Church 137
Bremen 133
Changsha 130
London 123
Pisa 118
Chicago 116
Ogden 116
Hebei 113
Jiaxing 98
Tianjin 98
Frankfurt am Main 94
Brussels 86
Lancaster 86
Grafing 84
Dakar 80
Washington 80
Hefei 79
Norwalk 75
Los Angeles 70
Guangzhou 63
Fuzhou 61
Düsseldorf 57
Hangzhou 57
Jinan 57
Orange 57
Verona 50
Auburn Hills 44
Marseille 44
Pune 44
Lagos 35
Dallas 34
Warsaw 33
Zhengzhou 32
Changchun 29
Toronto 29
Lanzhou 28
Ningbo 28
San Francisco 28
Seacroft 28
Phoenix 27
Quanzhou 27
Cotonou 26
Detroit 26
Indiana 26
Manchester 26
Provo 25
Helsinki 24
Wuhan 24
Nürnberg 23
São Paulo 22
Tappahannock 22
Munich 20
Chengdu 19
Naples 19
Council Bluffs 17
Costa Mesa 16
Kocaeli 16
Totale 61.979
Nome #
RISULTATI AD UN ANNO NEL TRAPIANTO SIMULTANEO DI PANCREAS-RENE: LA SCELTA PREEMPTIVE E’ VANTAGGIOSA? 4.459
ACE-INHIBITION PROTECTS PANCREATIC HUMAN ISLETS FROM GLUCOTOXICITY AND IMPROVES THE FUNCTION OF ISLETS FROM TYPE 2 DIABETIC PATIENTS 4.107
UN INSOLITO CASO DI IPOGLICEMIA IPERINSULINEMICA DA NESIDIOBLASTOSI E INSULINOMA 511
Gestational diabetes, inflammation, and late vascular disease 199
Q192R PARAOXONASE(PON)1 POLYMORPHISM, INSULIN SENSITIVITY AND ENDOTHELIAL FUNCTION IN ESSENTIAL HYPERTENSIVE MEN 194
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial 189
Insulin sensitivity, binding, and kinetics in pancreatogenic and type I diabetes 186
G-protein-coupled receptor 40 (GPR40) expression in human pancreatic 185
Insulin resistance in Cushing's syndrome. 183
Activation of the hexosamine pathway leads to phosphorylation of IRS-1 on Ser307 and Ser612 and impairs the phosphatidylinositol 3-kinase/Akt/mTOR insulin biosynthetic pathway in RIN pancreatic {beta}-cells 183
G-protein-coupled receptor 40 (GPR40) expression and its regulation in human pancreatic islets: The role of type 2 diabetes and fatty acids 182
Dipeptidyl peptidase-4 inhibitors can minimize the hypoglycaemic burden and enhance safety in elderly people with diabetes 176
Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial. 175
Alpha-Adducin and angiotensin-converting enzyme polymorphisms in hypertension: evidence for a joint influence on albuminuria JOURNAL OF HYPERTENSION JUN 2006 VL 24 IS 6 BP 1217 EP 1217 171
Evidence for two distinct phenotypes of chronic kidney disease in individuals with type 1 diabetes mellitus 171
Absence of islet alpha cell function in pancreatectomized patients. 170
Type 2 diabetes mellitus worsens arterial stiffness in hypertensive patients through endothelial dysfunction. 170
Effects of insulin treatment on ketone body production and carnitine-palmitoyl-transferase (CPT) activity in the isolated perfused liver from streptozotocin diabetic rats. 169
Gliclazide potentiates suppression of hepatic glucose production in non-insulin-dependent diabetic patients 164
Prevalence and risk factors for gestational diabetes assessed by universal screening 164
The antiketogenic effect of alanine in normal man: evidence for an alanine-ketone body cycle. 163
ACE/AACE consensus conference on the implementation of outpatient management of diabetes mellitus: consensus conference recommendations. 160
A call to action - the UN Resolution on diabetes 160
The contribution of hyperglycaemia and hypoinsulinaemia to the insulin resistance of streptozotocin-diabetic rats 159
Metabolic effects of moderate alcohol intake with meals in insulin-dependent diabetics controlled by artificial endocrine pancreas (AEP) and in normal subjects. 158
Pancreas transplant alone (PTA) in type 1 diabetic patients (T1DM): A 3-yr metabolic and diabetic complications follow-up 158
Body composition study in the elderly: comparison between tritium dilution method and dual photon absorptiometry 157
Dissociation of the effects of epinephrine and insulin on glucose and protein metabolism. 155
An off-the-shelf instant contact casting device for the management of diabetic foot ulcers - A randomized prospective trial versus traditional fiberglass cast 153
Hyperalaninaemia is an early feature of diabetes secondary to total pancreatectomy. 152
Effect of insulin replacement on intermediary metabolism in diabetes secondary to pancreatectomy 152
Serum gamma-glutamyltransferase levels are related to insulin sensitivity and secretion in subjects with abnormal glucose regulation 152
Effect of diabetes on hospitalization for ischemic stroke and related in-hospital mortality. A study in Tuscany, Italy, over years 2004-2011 151
ACE gene insertion/deletion polymorphism modulates capillary permeability in hypertension 151
Type 2 diabetes mellitus: focus on new treatments and special populations 150
Dipeptidyl peptidase 4 (DPP-4) inhibitors and their role in Type 2 diabetes management 150
A Common Polymorphism in the Promoter of UCP2 Contributes to the Variation in Insulin Secretion in Glucose-Tolerant Subjects 150
Metabolic control during total parenteral nutrition: use of an artificial endocrine pancreas. 149
Simultaneous pancreas-kidney transplantation is improved by living kidney donation program 148
We have the evidence, we need to act to improve diabetes care 148
Glucose transporter 2 gene polymorphisms and beta-cell function in isolated human pancreatic islets 148
Functional and survival analysis of isolated human islets 148
Diabetes programme facts and figures 147
Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo 147
What therapy do our NIDDM patients need? Insulin releasers 146
Effect of glyburide on glycemic control, insulin requirement, and glucose metabolism in insulin-treated diabetic patients 145
SINGLE CENTER, OPEN, PROSPECTIVE, RANDOMIZED, PILOT STUDY COMPARING CYCLOSPORINE VERSUS TACROLIMUS IN SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTATION 145
Successful solitary pancreas transplantation with portal-enteric drainage following unsuccessful islet cell transplantation 145
The vascular effects of doxazosin in hypertension complicated by metabolic syndrome 145
Portal enteric-drained solitary pancreas transplantation without surveillance biopsy: is it safe? 145
Selective screening for GDM in Italy: application and effectiveness of National Guidelines 144
ROLE OF G-PROTEIN-COUPLED RECEPTOR 40 (GPR40) IN NON-DIABETIC AND TYPE 2 DIABETIC PANCREATIC ISLETS. 144
Effect of streptozotocin in a case of glucagon-secreting malignant islets-cell tumor. 143
PPARG2 Pro12Ala and ADAMTS9 rs4607103 as "insulin resistance loci" and "insulin secretion loci" in Italian individuals. The GENFIEV study and the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 4 143
The role of peripheral benzodiazepine receptors on the function and survival of isolated human pancreatic islets 143
Long-Term (5 Years) Efficacy and Safety of Pancreas Transplantation Alone in Type 1 Diabetic Patients 143
Effect of metformin on insulin-stimulated glucose turnover and insulin binding to receptors in type II diabetes. 142
Fluctuations in glycaemia in clinical diabetes mellitus type 2 are not associated with carotid intima-media thickening. 142
Prognostic implications of diabetes phenotyping: new concepts for an old disease 142
Optimizing management of metabolic syndrome to reduce the risk: focus on life-style 142
null 142
Hyperglucagonemia and insulin-mediated glucose metabolism 141
Pathogenetic mechanisms and cardiovascular risk: differences between HbA(1c) and oral glucose tolerance test for the diagnosis of glucose tolerance 141
Gliclazide protects human islet beta-cells from apoptosis induced by intermittent high glucose 141
Gliclazide protects isolated human islets from apoptosis induced by intermittent high glucose: the role of oxidative stress 140
Glucagon-like peptide-1 (GLP-1) secretion in women with gestational diabetes mellitus during and after pregnancy 140
Insulin receptors on circulating blood cells from patients with pancreatogenic diabetes: a comparison with type I diabetes and normal subjects. 139
Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin 139
1-Hour OGTT Plasma Glucose as a Marker of Progressive Deterioration of Insulin Secretion and Action in Pregnant Women. 139
Effect of prolonged overnight fasting on energy metabolism in non-insulin-dependent diabetic and non-diabetic subjects 139
Retrospective analysis of daily glucose profile in type 1 diabetic patients with continuous subcutaneous insulin infusion (CSII) 138
Altered autophagy in the pancreatic beta cells of human type 2 diabetes 138
Oxidative stress in isolated human pancreatic islets: possible role of frataxin 137
Maternal metabolic control and perinatal outcome in women with gestational diabetes mellitus treated with lispro or aspart insulin: comparison with regular insulin 137
Epigenetic regulation of PGC-1 alpha inhuman type 2 diabetic islets and effect on insulin secretion 137
An alternative and simple method to consistently prepare viable isolated human islets for clinical transplantation 137
Microvascular complications burden (nephropathy, retinopathy and peripheral polyneuropathy) affects risk of major vascular events and all-cause mortality in type 1 diabetes: A 10-year follow-up study 137
High insulin levels impair intracellular receptor trafficking in human cultured myoblasts 136
Insulin secretion defects of human type 2 diabetic islets are corrected in vitro by a new reactive oxygen species scavenger. 136
The presence of retinopathy in patients with secondary diabetes following pancreatectomy or chronic pancreatitis. 135
Is there a local "incretin system" in human pancreatic islets? 135
Is maternal educational level a risk factor for gestational diabetes in Caucasian women? 135
Basal insulin and cardiovascular and other outcomes in dysglycemia. 135
Effects of prolonged in vitro exposure to sulphonylureas on the function and survival of human islets 135
Ninety-five percent insulin independence rate 3 years after pancreas transplantation alone with portal-enteric drainage 135
Effects of bariatric surgery on brain glucose metabolism and cognitive function: insight from dynamic FDG PET/CT study 135
Reconstructing the rate of appearance of subcutaneous insulin by deconvolution. 134
Mechanisms of fasting hypoglycemia and concomitant insulin resistance in insulinoma patients 134
Beta- and alpha-cell dysfunction in type 2 diabetes 134
Pancreas transplant alone (PTA) in type 1 diabetic patients (T1DM): a 3-year follow-up 134
Insulin Resistance and Lipid Disorders 134
Cytochrome P450 2J2 polymorphism in healthy Caucasians and those with diabetes mellitus 133
Elevated non-esterified fatty acids impair nitric oxide independent vasodilation, in humans: evidence for a role of inwardly rectifying potassium channels 133
The beneficial effects of pancreas transplant alone on diabetic nephropathy 133
C-reactive protein and metabolic syndrome in women with previous gestational diabetes 133
Cystatin C as a marker of renal function immediately after liver transplantation. 133
Correlation of endothelial progenitor cells with carbohydrate metabolism in prediabetic and diabetic patients 132
Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion. 132
Grain and bean lysates improve function of endothelial progenitor cells from human peripheral blood: involvement of the endogenous antioxidant defenses. 132
Exenatide modulates visual cortex responses 132
Totale 23.515
Categoria #
all - tutte 210.387
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 210.387


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205.744 0 0 0 0 0 0 1.360 995 1.405 724 1.054 206
2020/20216.203 679 272 563 257 615 269 572 598 594 495 335 954
2021/20228.379 241 610 186 543 1.596 1.183 213 441 297 302 462 2.305
2022/20237.982 1.152 730 381 800 1.086 1.161 86 685 1.253 84 470 94
2023/202416.714 1.376 1.129 1.122 568 1.230 1.295 172 192 162 8.525 151 792
2024/20256.488 131 916 274 1.145 1.266 1.718 1.038 0 0 0 0 0
Totale 82.024